ALS drug gets rare second review at high-stakes FDA meeting
A panel of federal health advisers has voted to recommend approval for an experimental drug to treat Lou Gehrig's disease
Stay updated with breaking news from Billy Dunn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A panel of federal health advisers has voted to recommend approval for an experimental drug to treat Lou Gehrig's disease
Patients with the deadly neurological disease have rallied behind the drug from Amylyx Pharma and are lobbying the FDA for approval.
WASHINGTON (AP) -- A panel of federal health advisers voted Wednesday to recommend approval for an experimental drug to treat Lou Gehrig's disease, a
Patients with the deadly neurological disease have rallied behind the drug from Amylyx Pharma and are lobbying the FDA for approval.
Patients with the deadly neurological disease have rallied behind the drug from Amylyx Pharma and are lobbying the FDA for approval.